A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/1994
12/08/1994	WO1994027594A2 Stable copper(i) complexes and methods related thereto
12/08/1994	WO1994027590A1 New procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis
12/08/1994	WO1994027584A2 Arylating medicaments
12/08/1994	WO1994027440A1 Anti-infective agents
12/08/1994	WO1994027426A1 Methods of using bcl-2 for the therapeutic treatment and prevention of diseases
12/08/1994	WO1994024296A3 Recombinant bovine herpesvirus type 1 vaccines
12/08/1994	WO1994021807A3 Defective mutant non-retroviral virus (e.g. hsv) as vaccine
12/08/1994	WO1994016096A3 Method to predict active growth of bacteria adhered to a surface
12/08/1994	WO1994012165A3 Enzyme inhibitors
12/08/1994	CA2337581A1 Optically pure salts of pyridinylmethyl sulfinyl-1h-benzimidazole compounds and intermediates in the preparation therefor
12/08/1994	CA2163640A1 Stable copper (i) complexes and their use as active therapeutic substances
12/08/1994	CA2163550A1 Adjuvants for vaccines against respiratory syncytial virus
12/08/1994	CA2163459A1 Arylating medicaments
12/08/1994	CA2163438A1 Regulator of contact-mediated hemolysin
12/08/1994	CA2162488A1 Triazole derivative or salt thereof, and antifungal agent containing the same
12/08/1994	CA2141028A1 Hepatotropic conjugates of antiviral drugs, carriers thereof and pharmaceutical compositions containing them
12/07/1994	EP0627430A1 Process for converting loracarbef dihydrate to loracarbef monohydrate
12/07/1994	EP0627429A1 Loracarbef isopropanolate and a process for converting loracarbef isopropanolate to loracarbef monohydrate
12/07/1994	EP0627006A1 Hybrid dna that codes for a subunit of a bacterial toxin with a hemolysin.
12/07/1994	EP0627005A1 Ibv spike protein (2)
12/07/1994	EP0626858A1 Antiviral agent
12/07/1994	EP0605690A4 Povidone hydrogen peroxide preservation of blood, tissues and biological fluids.
12/07/1994	EP0416035B1 Amphiphilic peptides and use thereof
12/07/1994	CN1095935A Chinese drug pill for treatment of cold
12/06/1994	US5371199 Substituted porphyrins, porphyrin-containing polymers, and synthetic methods therefor
12/06/1994	US5371101 Azole compounds, their production and use
12/06/1994	US5371090 Bactericides, feed additives
12/06/1994	US5371076 9-[(substituted glycyl)amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines
12/06/1994	US5371000 Process for the production of ergoline derivatives
12/06/1994	US5370873 Therapeutic compounds derived from the neem tree
12/06/1994	US5370872 Coupling lipid a free polysaccharide to toxin A
12/06/1994	US5370869 Infusion into patient platelet concentrate that has been in contact with povidone-iodine or povidone-hydrogen peroxide or mixture to inactivate or destroy pathogenic microorganism
12/06/1994	CA2125129A1 Dinucleotide analogues, intermediates therefor and oligonucleotides derived therefrom
12/06/1994	CA1333391C Therapeutic nucleosides
12/06/1994	CA1333390C Fluorinated nucleosides and process for treating retrovirus infections therewith
12/06/1994	CA1333369C 3-propadienyl penicillin derivatives and intermediates
12/06/1994	CA1333361C Antiviral compounds
12/04/1994	CA2125054A1 Antiviral agents
11/1994
11/30/1994	EP0626452A1 Vaccine against Streptococcus suis infection
11/30/1994	EP0626447A1 Monoclonal antibodies and Fv specific for cd2 antigen
11/30/1994	EP0626389A1 Recombinant antibodies specific for TNF-alpha
11/30/1994	EP0626383A1 Palan'amine: a pharmacologically active compound from a sponge
11/30/1994	EP0626177A2 Nutrition for persons infected with human immunodeficiency virus
11/30/1994	EP0626173A1 Aerosol composition containing fusafungine
11/30/1994	EP0626008A1 Vaccine containing acemannan as an adjuvant
11/30/1994	EP0625990A1 Glycoprotein complexes and glycoproteins
11/30/1994	EP0625984A1 Cephalosporin compounds
11/30/1994	EP0625981A1 Azabicyclo compounds as calcium channel antagonists
11/30/1994	EP0625979A1 Azabricyclic compounds as calcium channel antagonists
11/30/1994	EP0422164B1 Large multivalent immunogen
11/30/1994	CN1026788C Triazole antifungal agents
11/29/1994	US5369102 2-substituted alkyl-3-carboxy carbopenems as antibiotics and a method of producing them
11/29/1994	US5369101 Expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles
11/29/1994	US5369098 Hydroxymethyl cyclobutyl purines
11/29/1994	US5369093 Lipopeptide derivatives
11/29/1994	US5369025 Recombinant fowlpox vaccine for protection against Marek's disease
11/29/1994	US5369019 Genetic engineering
11/29/1994	US5368865 Suspendible composition and process for preparing the same
11/29/1994	US5368853 Leukoregulin anti-viral therapy
11/29/1994	CA2124252A1 Method of reducing or preventing bone marrow hypoplasia
11/29/1994	CA2124027A1 Dna originating in a non-a non-b hepatitis virus gene and constituting polypeptide
11/29/1994	CA1333285C Morpholinoethylester of mycophenolic acid and derivatives thereof
11/26/1994	CA2124179A1 New fusafungine-based medicinal spray formulation, a process for its production and pharmaceuticals containing same
11/24/1994	WO1994026925A2 Processes for producing an enzyme
11/24/1994	WO1994026921A1 Production of toxin binding biopolymers, use thereof
11/24/1994	WO1994026904A1 Hepatitis b virus mutants, reagents and methods for detection
11/24/1994	WO1994026877A1 Ribozyme gene therapy for hiv infection and aids
11/24/1994	WO1994026785A1 Composite synthetic peptide construct eliciting neutralizing antibodies and cytotoxic t lymphocytes against hiv
11/24/1994	WO1994026784A1 Composition of antibodies against hepatitis b surface antigen
11/24/1994	WO1994026780A1 Synthetic aglucodalbaheptide antibiotics
11/24/1994	WO1994026776A1 Therapeutic compounds
11/24/1994	WO1994026750A1 Deoxythiomarinol derivatives, process and intermediates for their preparation and their use as microbicides and herbicides
11/24/1994	WO1994026736A1 Thioindole pyperidinyl derivatives used as antalgics
11/24/1994	WO1994026730A2 Novel aromatic nitro and nitroso compounds and their metabolites useful as anti-viral and anti-tumor agents
11/24/1994	WO1994026723A2 ras FARNESYL TRANSFERASE INHIBITORS
11/24/1994	WO1994026717A1 Hiv protease inhibitors useful for the treatment of aids
11/24/1994	WO1994026714A1 Novel deoxygalactonojirimycin derivatives
11/24/1994	WO1994026713A1 DERIVATIVES OF β, β-DIMETHYL-4-PIPERIDINEETHANAMINE AS INHIBITORS OF THE CHOLESTEROL BIOSYNTHESIS
11/24/1994	WO1994026708A1 Optically active 3-(1-(alkylamino))alkyl pyrrolidines
11/24/1994	WO1994026707A1 Vitamin d amide derivatives
11/24/1994	WO1994026312A1 METHODS AND COMPOSITIONS FOR DETECTING AND TREATING MYCOBACTERIAL INFECTIONS USING AN inhA GENE
11/24/1994	WO1994026306A1 Conserved motif of hepatitis c virus e2/ns1 region
11/24/1994	WO1994026305A1 Hiv immunogenic complexes
11/24/1994	WO1994026304A1 Otitis media vaccine
11/24/1994	WO1994026293A1 Immunologic enhancement with intermittent interleukin-2 therapy
11/24/1994	WO1994026285A1 Xenograft thymus
11/24/1994	WO1994026284A1 Use of modified tall-104 cells to treat cancer and viral diseases
11/24/1994	WO1994026277A1 Inhibition of tumor necrosis factor and nitric oxide production by retinoic acid
11/24/1994	WO1994026273A1 Acyclovir derivatives for topical use
11/24/1994	WO1994026263A2 Use of a transition metal complex for the treatment of septic shock
11/24/1994	WO1994026250A1 Method for treating neurological disorders
11/24/1994	WO1994016073A3 Methods and reagents for inhibiting furin endoprotease
11/24/1994	CA2163219A1 Immunologic enhancement with intermittent interleukin-2 therapy
11/24/1994	CA2163129A1 Ribozyme gene therapy for hiv infection and aids
11/24/1994	CA2163001A1 Derivatives of .beta.,.beta.-dimethyl-4-piperidineethanamine as inhibi tors of the cholesterol biosynthesis
11/24/1994	CA2162990A1 Inhibition of tumor necrosis factor and nitric oxide production by retinoic acid
11/24/1994	CA2162868A1 Methods and compositions for detecting and treating mycobacterial infections using an inha gene
11/24/1994	CA2162574A1 Acyclovir derivatives for topical use
11/24/1994	CA2162556A1 Novel aromatic nitro and nitroso compounds and their metabolites useful as anti-viral and anti-tumor agents
11/24/1994	CA2162370A1 Composition of antibodies against hepatitis b surface antigen

1 ... 1644 1645 1646 1647 1648 1649 1650 1651 1652 1653 1654 1655 1656 1657 1658 1659 1660 1661 1662 1663 1664 ... 1798